Endocardite de libbman-sacks e lúpus eritematoso sistêmico com manifestações hematológicas graves:: relato de caso

• Autor(a) principal: Freitas Viégas Fernandes, Hugo
• Data de Publicação: 2023
• Outros Autores: Abreu Lhamas , Laura, Rangel da Silva , Laura Aparecida, Martins Gomes , Nicolas, Nunes Teixeira , Anderson
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista Científica da Faculdade de Medicina de Campos
• Texto Completo: https://revista.fmc.br/ojs/index.php/RCFMC/article/view/698
• topic: Pancitopenia; Lupus Eritematoso Sistêmico; Endocardite; Ciclofosfamida

ABSTRACT The authors present the case of a 35-year-old female patient, diagnosed with Systemic Lupus Erythematosus (SLE) with ANTI-DNA REAGENT 1/160 and lupus nephritis, submitted to pulse therapy with methylprednisolone and cyclophosphamide followed by oral prednisone, presenting with pancytopenia important 4 months later, requiring new pulse therapy, initiation of treatment with azathioprine and, later, mycophenolate. The description of this case is justified by the atypical behavior of SLE, serving as a reference for diagnosis, treatment and case management of cases with similar behavior. METHODOLOGY: The information contained in this study was obtained by reviewing the medical record, with the free and informed consent form, containing information on the physical examination performed and the results of complementary exams, recording the methods of diagnosis and treatment that the patient underwent and reviewing of literature.   Keywords: lupus, cyclophosphamide, genetic disease, chemotherapy